John Leaman | Chief Financial & Business Officer |
Adrian Adams | Chairman of the Board & Chief Executive Officer |
Len Paolillo | Chief Commercial Officer |
Ken Cacciatore | Cowen |
Laura Chico | Wedbush |
Eddie Hickman | Guggenheim Securities |
Good morning, ladies and gentlemen, and Welcome to Impel Pharmaceuticals’ First Quarter 2022 Earnings Corporate Update Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session. Instructions on how to participate will be given at that time. [Operator Instructions] As a reminder, today's conference call is being recorded.